Kipp Weiskopf
Harvard University
H-index: 29
North America-United States
Top articles of Kipp Weiskopf
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction | The Journal of Clinical Investigation | Kyle Vaccaro Juliet Allen Troy W Whitfield Asaf Maoz Sarah Reeves | 2024/3/14 |
Phagocytic cooperativity by tumour macrophages | Nature Biomedical Engineering | Asaf Maoz Kipp Weiskopf | 2023/9 |
Enhanced depletion of targeted cells with cd47 blockade and an immune costimulatory agonist | 2023/8/17 | ||
Cd47 targeted therapies for the treatment of infectious disease | 2023/12/21 | ||
MMD collaborates with ACSL4 and MBOAT7 to promote polyunsaturated phosphatidylinositol remodeling and susceptibility to ferroptosis | Cell reports | Vaishnavi V Phadnis Jamie Snider Venkateshwari Varadharajan Iyappan Ramachandiran Amy A Deik | 2023/9/26 |
Targeted therapies prime lung cancer cells for macrophage-mediated destruction | Cancer Research | Kyle Vacarro Juliet Allen Asaf Maoz Sarah Reeves Aaron Hata | 2022/6/15 |
Complement C3 deficiency enhances anti-CD47 efficacy in murine ovarian cancer model. | The Journal of Immunology | Sora Suzuki Thejaswini Giridharan ANM Khan Tiffany R Emmons Michael B Yaffe | 2022/5/1 |
High affinity sirp-alpha reagents and methods of using | 2022/3/3 | ||
189P IL-10 enhances macrophage phagocytosis of cancer cells in response to CD47 blockade and opsonizing antibodies | Immuno-Oncology and Technology | A Maoz J Allen K Vaccaro J Velarde K Weiskopf | 2022/12/1 |
Engraftment of stem cells with a combination of an agent that targets stem cells and modulation of immunoregulatory signaling | 2022/11/3 | ||
MMD scaffolds ACSL4 and MBOAT7 to promote polyunsaturated phospholipid synthesis and susceptibility to ferroptosis | Biorxiv | Vaishnavi V Phadnis Jamie Snider Victoria Wong Kyle D Vaccaro Tenzin Kunchok | 2022/9/2 |
Targeting the CD47-SIRPα pathway promotes macrophage-mediated trogocytosis of ovarian cancer cells | Gynecologic Oncology | Aaron Varghese Sora Suzuki Thejaswini Giridharan Tiffany Emmons ANM Nazmul Khan | 2021/8/1 |
High affinity sirp-alpha reagents | 2013/7/25 | ||
Compositions and methods for inducing phagocytosis of MHC class I positive cells and countering anti-CD47/SIRPA resistance | 2021/1/12 | ||
Use of anti-CD47 agents to enhance immunization | 2021/10/26 | ||
Targeted therapy for small cell lung cancer | 2021/9/9 | ||
Reagensi sirp-alfa visokog affiniteta | 2020/8/31 | ||
Højaffine sirp-alpha-reagenser | 2020/8/10 | ||
Evolutionarily conserved resistance to phagocytosis observed in melanoma cells is insensitive to upregulation of pro-phagocytic signals and to CD47 blockade | Melanoma research | Katie L Anderson Kristin M Snyder Daisuke Ito Debra C Lins Lauren J Mills | 2020/4/1 |
Anti SIRP-α antibodies and bi-specific macrophage enhancing antibodies | 2020/9/22 |
